APPLICATION
ANDA209921
TYPE
ANDA
ORIGINAL APPROVAL
2019-05-07
LATEST ACTION
2021-08-27
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued
Products
LUXZYLADiscontinued
PENICILLAMINE 250MG · CAPSULE · ORAL
Approval history
2021-08-27Labeling · Supplement 6 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.